CD44 and carcinoma: Although the nature of CSCs is still the subject of debate, CD44+ human carcinomas are highly malignant and resistant to therapy, and the presence of CD44 has been shown to confer increased metastatic potential, properties that are frequently associated with CSCs [38, 49].